Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
Researchers have found that pharmacy benefit managers (PBMs) -- organizations that negotiate access to medicines for most patients in the United States -- steer patients to use their own pharmacies.
A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly ...
There’s a major change in 2025 to Medicare’s prescription drug coverage. This year, there’s a new $2,000 cap on annual out-of ...
A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found those insured through Medicare Advantage received less expensive cancer ...
More than 70,000 seniors in Washington state will save hundreds or thousands of dollars each year thanks to the new annual cap on out-of-pocket prescription drug costs for folks on Medicare Part D, ...